登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600325 证券简称：华发股份 公告编号：2025-049 本公司董事局及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 每股分配比例 A股每股现金红利0.104元 ● 相关日期 ■ ● 差异化分红送转： 是 一、通过分配方案的股东大会届次和日期 珠海华发实业股份有限公司 2024年年度权益分派实施公告 本次利润分配方案经公司2025年4月7日的2024年年度股东大会审议通过。 二、分配方案 1.发放年度：2024年年度 2.分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分公司（以下简 称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《公司法》《上市公司股份回购规则》等有关规定，公司回购专用证券账户中的股份7,485,000股华 发股份股票不参与本次利润分配。 3.差异化分红送转方案： （1）差异化分红的具体方案 公司于2025年4月7日召开2024年年度股东大会，审议通过的2024年年度利润分配方案为：公司拟 ...

Group 1: Company Operations - The construction of the factory in the United States is currently in progress, with updates to be disclosed according to regulatory requirements [3] - The company reported good export performance for cellulose ether in May 2025 [4] - The price of cellulose ether has remained stable in 2025, with no significant fluctuations observed [5][6] Group 2: Financial and Strategic Plans - The company's 2025 performance is expected to grow, with detailed plans available in the 2024 annual report [7] - The strategy to address U.S. trade tariffs includes reserving 4 to 6 months' worth of plant-based capsules in the U.S. warehouse, classified as accounts receivable in financial statements [7] - The purpose of the share buyback is to convert shares into convertible bonds, with plans to implement the buyback at an appropriate time following regulatory approval [7] Group 3: Future Projections and Risks - The U.S. factory will only produce plant-based capsules, with cellulose ether sourced from domestic imports, which may still face high tariff risks [8]

Core Viewpoint - The article summarizes important announcements from various listed companies in the Shanghai and Shenzhen stock markets, providing insights for investors regarding their operational status, strategic moves, and financial activities [2]. Company Announcements - Lijun Co. confirmed that its operational status is normal and there are no undisclosed significant matters affecting its stock price, despite recent trading volatility [3]. - Wolong Nuclear Materials plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy and brand image, pending shareholder and regulatory approvals [4]. - Aikelan announced the termination of a share transfer agreement with a private equity fund, which will not affect the company's control or governance structure [6]. - Wanda Film's subsidiary plans to invest in Lezi Tiancheng and engage in strategic cooperation, focusing on IP toy product development and marketing [7]. - Sunshine Nuohuo intends to acquire 100% of Jiangsu Langyan Life Science Technology Co., enhancing its R&D and production capabilities, with stock resuming trading on May 13 [8]. Shareholding Changes - Ruineng Technology's controlling shareholder plans to reduce its stake by up to 2.89% through block trades and public offerings, with a reduction period from June 4 to September 3, 2025 [9]. - Tianqiao Hoisting's controlling shareholder plans to increase its stake by investing between 75 million to 150 million yuan, with a maximum purchase price of 5 yuan per share [10]. - Boyun New Materials' shareholder plans to reduce its stake by up to 3% within three months starting from June 5, 2025 [11]. Share Buybacks - Guomai Culture plans to repurchase shares worth between 50 million to 100 million yuan, with a maximum repurchase price of 16 yuan per share, to be completed within 12 months [12]. - Haizheng Pharmaceutical intends to repurchase shares worth between 50 million to 100 million yuan for an employee stock ownership plan, with a maximum price of 13 yuan per share [13]. Major Contracts - China CNR recently signed significant contracts totaling approximately 54.74 billion yuan, accounting for about 22.2% of its projected revenue for 2024, covering various sectors including urban rail vehicles and wind energy equipment [14].

Group 1: Revenue and Market Outlook - The company aims for a sales revenue target of 11.8 billion CNY for 2025, with an ambitious goal of 12.5 billion CNY [2] - The impact of the complex international trade environment on the company includes direct and indirect effects on compressor exports, with ongoing assessments being conducted [2] - The domestic market for closed piston compressors is expected to see a year-on-year decline of approximately 1% in 2025, while the export market is projected to grow by about 1% [3] Group 2: Business Development and Client Structure - The company is focusing on the development of automotive air conditioning compressors, with over 95% of its major clients being domestic [3] - The company is committed to enhancing technology research and development, optimizing product structure, and expanding its client base to close the gap with industry leaders [3] Group 3: Shareholder Returns and Stock Buyback - The company has increased cash dividends in recent years and plans to use 150 million to 300 million CNY for stock buybacks to reduce registered capital and implement equity incentives [3] - A proposal for the stock buyback was disclosed on April 10, with the company committed to following regulatory procedures for execution [6] Group 4: Competitive Advantages - The company holds a leading position in the closed piston compressor industry, with core advantages in technology research, customer resources, and brand recognition [4] - Continuous efforts are being made to enhance product competitiveness, adjust product structure, and improve operational efficiency to tackle market competition [4] Group 5: Production Capacity and Material Costs - The Mexico plant has achieved a total capacity of 4 million units per year, with significant customer factory audits completed [5] - Fluctuations in raw material prices may impact profits, but strategic partnerships with suppliers are in place to mitigate these effects [6]